Investment
Features
FeesSafety
Academy
More
Pluang+

Arthur J. Gallagher & Co. schedules virtual quarterly management meeting on Sept 23 to discuss financial outlook.

Market News
03 Sep 2026
PRNewsWire
View Source
Neutral
pluang ai news

Arthur J. Gallagher & Co., a global insurance brokerage and consulting firm, will hold its quarterly management meeting virtually on September 23, 2026. The meeting will feature presentations from the company's operating and financial leaders on business operations and financial outlook, followed by a Q&A session with investors. The live conference call will be accessible via the company's website, with a replay available until September 30. This meeting provides investors with insights into the company's current performance and future prospects.

More News

Shell expands with $16.5B ARC Resources buy and full Tri Star Energy takeover

Shell expands with $16.5B ARC Resources buy and full Tri Star Energy takeover

Shell plc completed a $16.5 billion acquisition of ARC Resources Ltd., boosting its production by 370,000 barrels of oil equivalent per day and targeting 4% annual growth through 2030. The company also agreed to acquire the remaining 67% of Tri Star ...

Company Fundamentals
Bullish
2 hours ago
Teladoc Health cuts 2026 revenue forecast amid insider stock sale and BetterHelp struggles

Teladoc Health cuts 2026 revenue forecast amid insider stock sale and BetterHelp struggles

Teladoc Health's BetterHelp segment saw an 11.6% revenue drop and a near-zero profit margin in Q2 2026, partly due to a shift from cash to insurance payments. The company lowered its full-year 2026 revenue guidance to $2.36-$2.45 billion from $2.48-$...

Market News
Bearish
2 hours ago
Zscaler shares jump after beating Q4 earnings and revenue estimates, driven by AI focus.

Zscaler shares jump after beating Q4 earnings and revenue estimates, driven by AI focus.

Zscaler reported strong fiscal Q4 results, surpassing analyst expectations with an EPS of $1.19 and revenue of $898.19 million, a 25% year-over-year growth. The company credits its robust performance to strategic investments in artificial intelligenc...

Company Fundamentals
Bullish
2 hours ago
Ciena shares drop 11% despite strong Q3 earnings and AI-driven demand growth.

Ciena shares drop 11% despite strong Q3 earnings and AI-driven demand growth.

Ciena reported a strong Q3 2026 with adjusted EPS of $2.11, a 215% increase year-over-year, and revenue up 37% to $1.67 billion, driven by high demand from cloud and AI data centers. The company’s backlog rose to $8.5 billion, signaling strong future...

Company Fundamentals
Neutral
3 hours ago
Kazia Therapeutics advances cancer drug trials with strong financial backing and upcoming earnings report.

Kazia Therapeutics advances cancer drug trials with strong financial backing and upcoming earnings report.

Kazia Therapeutics is progressing its main cancer drug candidate, paxalisib, into Phase 2 trials for colorectal cancer and planning a new breast cancer study. The company recently raised $40 million to support these developments and maintains a stron...

Company Fundamentals
Bullish
3 hours ago
banner-footerbanner-footer

Invest & Trade with
#1 Award-Winning Investment Super App